Code Status Decisions for End-Stage Cancer—Resolving the Ethical Dissonance

Fawad A. Khan; Mohammed S. Khan; Ryan Pferdehirt

doi:10.1001/jamaoncol.2025.6100

January 29, 2026JAMA Oncology

Code Status Decisions for End-Stage Cancer—Resolving the Ethical Dissonance

View at Publisher

Ask AI

Bookmark

Share

Key Points

To address the disagreement between clinicians and patients regarding code status decisions in end-stage cancer cases.
Reviewed existing literature on code status decisions and ethical considerations
Analyzed the disparity between clinician and patient perspectives
Proposed ethical frameworks to guide decision-making
Identified common areas of disagreement in code status decisions
Outlined key ethical principles that can resolve these conflicts
Discussed the importance of communication between clinicians and patients

Implication

Viewpoint discusses disagreements in code status decisions for end-stage cancer, suggesting ethical resolutions.

Abstract

This Viewpoint discusses discordance in code status decisions between clinicians and patients with end-stage cancer and provides ethical frameworks for its resolution.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Khan et al. (2026) studied this question.

synapsesocial.com/papers/6980fcfcc1c9540dea80ec44 https://doi.org/10.1001/jamaoncol.2025.6100

View at Publisher

Ask AI

Bookmark

Share

Code Status Decisions for End-Stage Cancer—Resolving the Ethical Dissonance

Key Points

Implication

Abstract

Discussion

Cite This Study

Code Status Decisions for End-Stage Cancer—Resolving the Ethical Dissonance

Key Points

Implication

Abstract

Discussion

Cite This Study

Keep reading

More related papers

More from JAMA Oncology

Keep reading

More related papers

More from JAMA Oncology